Laparoscopic versus open pancreatoduodenectomy for pancreatic or periampullary tumours (LEOPARD-2): a multicentre, patient-blinded, randomised controlled phase 2/3 trialJony van Hilst, Ferry A.L.M. Eskens, Ignace H. J. T. de Hingh et al.|The Lancet. Gastroenterology & hepatology|2019Cited by 597
An Engineered IL15 Cytokine Mutein Fused to an Anti-PD1 Improves Intratumoral T-cell Function and Antitumor ImmunityYuanming Xu, Javier Chaparro‐Riggers, Lucia Campos Carrascosa et al.|Cancer Immunology Research|2021Cited by 98
Development and provider assessment of a new oncology network with care pathways for gastrointestinal cancer patients: the collaborative approachB. Ten Haaft, Myriam Chalabi, Mark I. van Berge Henegouwen et al.|BMC Cancer|2025Cited by 1